Page last updated: 2024-08-21

pyrazines and Carcinoma, Adenosquamous

pyrazines has been researched along with Carcinoma, Adenosquamous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, M; Gohda, H; Harada, K; Ikeda, Y; Kawamata, H; Kinoshita, M; Nakashiro, K; Nishida, T; Ono, K; Sato, M; Yoshida, H	1

Other Studies

1 other study(ies) available for pyrazines and Carcinoma, Adenosquamous

Article	Year
Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene. Cancer letters, 1997, Jan-30, Volume: 112, Issue:2 Topics: Antineoplastic Agents; Carcinoma, Adenosquamous; Cell Differentiation; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Pyrazines; Quinolines; Salivary Gland Neoplasms; Transforming Growth Factor beta; Tumor Cells, Cultured	1997

Article

Year

Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene.

Cancer letters, 1997, Jan-30, Volume: 112, Issue:2

Topics: Antineoplastic Agents; Carcinoma, Adenosquamous; Cell Differentiation; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Pyrazines; Quinolines; Salivary Gland Neoplasms; Transforming Growth Factor beta; Tumor Cells, Cultured

1997